A Rare Presentation of Checkpoint Inhibitor Induced Distal RTA

Immune checkpoint inhibitors have opened a new era in treating advanced malignancies, resulting in a rapid increase in utilization, given the remarkable clinical outcomes. The incidence of immune-related adverse events increased due to the immunologic effects of these therapeutic agents. However, im...

Descripción completa

Detalles Bibliográficos
Autores principales: Doodnauth, Andrew V., Klar, Miriam M., Malik, Zohra R., Patel, Krunal H., McFarlane, Samy I.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2021
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8310435/
https://www.ncbi.nlm.nih.gov/pubmed/34327031
http://dx.doi.org/10.1155/2021/7406911

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8310435/
https://www.ncbi.nlm.nih.gov/pubmed/34327031
http://dx.doi.org/10.1155/2021/7406911

Ejemplares similares